GC Biopharma Corp.
KOSPI
Shareholding pattern
As reported to FSS/DART, 2025-12-31.
| Largest shareholder group | 51.41% |
|---|---|
| Minority shareholders | 40.00% |
| Top 10 holders | 51.41% |
| Total shareholders | 47,617 |
Who owns the company
Share of shares outstandingLargest shareholder & related parties 51.41%Minority shareholders 40%Institutions & other holders 8.59%
How to read this: the largest shareholder group is the controlling owner and related parties — a big slice means tight control. Minority shareholders are the many small holders. The remainder is mostly institutional and foreign money, which the regulator does not itemise separately.
Ownership detail
| Investor category | Holding % | Shareholders |
|---|---|---|
| Largest shareholder & related parties | 51.41% | — |
| Minority shareholders | 40.00% | 47,600 |
| Institutions & other holders | 8.59% | — |
How to read this: a high foreign or institutional share often means the stock is widely researched and more liquid; a high individual share means retail investors hold most of the company. Percentages are of voting units.
Largest shareholders
| S.No. | Shareholder | Shares | Stake % |
|---|---|---|---|
| 1 | ㈜녹십자홀딩스 | 5,850,482 | 50.06% |
| 2 | 허일섭 | 66,173 | 0.57% |
| 3 | (재)목암과학장학재단 | 50,910 | 0.44% |
| 4 | 허은철 | 29,014 | 0.25% |
| 5 | 박용태 | 10,455 | 0.09% |
| 6 | 박기준 | 100 | 0.00% |
| 7 | 강정훈 | — | 0.00% |
| 8 | 신웅 | 250 | 0.00% |
| 9 | 이진희 | 20 | 0.00% |
| 10 | 정재욱 | 250 | 0.00% |
Trust banks such as Master Trust and Custody Bank appear at the top of most Japanese registers: they hold shares on behalf of many underlying funds rather than owning them outright.